Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc (NY: ALC )

74.96 +0.76 (+1.02%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Alcon Inc

< Previous 1 2 Next >
Alcon Reports First Quarter 2022 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Results of 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries
From Alcon Inc. Corporate
Via Business Wire
Alcon to Deliver Robust Scientific Program at ASCRS 2022
From Alcon Inc. Investors
Via Business Wire
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
From Alcon Inc. Corporate
Via Business Wire
Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count
From Alcon Inc. Corporate
Via Business Wire
Alcon Publishes Agenda for 2022 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Reports Fourth Quarter and Full Year 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe
From Alcon Inc. Investors
Via Business Wire
Alcon to Launch DAILIES TOTAL1 Contact Lenses in the U.S. for Patients with Astigmatism
From Alcon Inc. Investors
Via Business Wire
Alcon Completes Acquisition of Ivantis, Inc., Bringing Hydrus Microstent into Its Global Surgical Portfolio
From Alcon Inc. Investors
Via Business Wire
Alcon Reports Third Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon Unveils Latest Evolution of Cataract Integration and Connectivity at AAO 2021
From Alcon Inc. Corporate
Via Business Wire
Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio
From Alcon Inc. Investors
Via Business Wire
Alcon #Academy21 Program to Showcase TOTAL30, Other Innovations that Meet Critical Patient and Practice Needs
From Alcon Inc. Corporate
Via Business Wire
Alcon Celebrates World Sight Day 2021 in Communities Worldwide with Programs for Improved Access to Eye Care
From Alcon Inc. Corporate
Via Business Wire
Alcon Honored with FutureEdge 50 Award
From Alcon Inc. Corporate
Via Business Wire
Alcon Reports Second Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon to Launch TOTAL30 as the First-and-Only Monthly Replacement, Water Gradient Contact Lens
From Alcon Inc. Investors
Via Business Wire
Alcon Reinforces Strength of Industry-Leading Ophthalmology Portfolio with Largest Surgical Device Scientific Presence at ASCRS 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Announces Executive Committee Changes
From Alcon Inc. Investors
Via Business Wire
Alcon to Showcase Vision Care Innovation, Including Clinical Data for its Forthcoming Reusable Monthly Lens TOTAL30, at BCLA 2021
From Alcon Inc. Investors
Via Business Wire
Alcon Reports First Quarter 2021 Results
From Alcon Inc. Investors
Via Business Wire
Alcon to Acquire U.S. Commercialization Rights to Ophthalmic Eye Drop Simbrinza
From Alcon Inc. Investors
Via Business Wire
Alcon Shareholders Approve All Binding Resolutions at the 2021 Annual General Meeting
From Alcon Inc. Investors
Via Business Wire
Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.
From Alcon Inc. Investors
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.